PHGDH and embryonal carcinoma: Silencing of PHGDH leads to reduced expression of master transcriptional regulators of self-renewal and pluripotency, i.e., Oct4, Nanog, Sox2, and Bmi1, and diminishes the capacity of tumorsphere formation in embryonal carcinoma stem cells, breast CSCs, and patient-derived brain CSCs.